Page 4 - Seriesc Financing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Wasabi Secures $112M Series C Financing, Sets Sights on Global Expansion and Company Growth Wasabi triples valuation as it continues to establish first hyperscale cloud storage architecture Boston, MA, April 29, 2021 (GLOBE NEWSWIRE) --  Wasabi, the hot cloud storage company, today announced $112M in Series C funding led by Fidelity Management & Research Company with participation from existing investors. The round follows Wasabi’s $27.5M in debt financing announced in January. The C round brings Wasabi’s total equity financing to $219 million. The valuation of the C round was roughl...

Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity by Healthcare Growth Partners (HGP) The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response.  Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated.  Over the course of the quarter, we observed $7 billion in private equity and venture capital investment across 158 companies.  By comparison, Q1 of 2020 saw $3.2 billion and 127 investments.  Health IT M&A ...

RTW Participates in $95 Million Financing Round in Monte Rosa Therapeutics RTW Venture Fund Limited (the "Company"), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the announcement by Monte Rosa Therapeutics, Inc. ("Monte Rosa") on 12 March 2021 of its completion of a $95 million Series C financing round. The Company, alongside other investment vehicles of RTW Investments, LP (the "Investment Manager"), confirms that it participated in the financing rou...

Inivata Raises $35 million in Second Close of Series C Financing February 04, 2021 07:00 ET | Source: Inivata Inivata Inivata Raises $35 million in Second Close of Series C Financing Funds will accelerate clinical development of RaDaR™ minimal residual disease assay and commercialization of InVisionFirst®-Lung Research Triangle Park, NC, USA and Cambridge, UK, 4 February 2021 -- Inivata, a leader in liquid biopsy, today announces it has raised $35 million (£25.7 million) in a second close of a Series C financing round. The round was led by Soleus Capital, who wer...